These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25256309)

  • 1. Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease.
    Seeman P
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1096. PubMed ID: 25256309
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
    Clark-Papasavas C; Dunn JT; Greaves S; Mogg A; Gomes R; Brownings S; Liu K; Nwosu B; Marsden P; Joemon J; Cleij M; Kessler R; Howard R; Reeves S
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1001-9. PubMed ID: 24578318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
    Reeves S; McLachlan E; Bertrand J; D'Antonio F; Brownings S; Nair A; Greaves S; Smith A; Taylor D; Dunn J; Marsden P; Kessler R; Howard R
    Brain; 2017 Apr; 140(4):1117-1127. PubMed ID: 28334978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA; Erlandsson K; Spencer EP; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
    Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Meisenzahl EM; Schmitt G; Gründer G; Dresel S; Frodl T; la Fougère C; Scheuerecker J; Schwarz M; Boerner R; Stauss J; Hahn K; Möller HJ
    Pharmacopsychiatry; 2008 Sep; 41(5):169-75. PubMed ID: 18763218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comfort, self-confidence, safety, and dopamine D2 receptor occupancy by antipsychotics.
    de Haan L; Lavalaye J; Booij J; Linszen D
    Am J Psychiatry; 2005 Aug; 162(8):1544-5. PubMed ID: 16055785
    [No Abstract]   [Full Text] [Related]  

  • 8. The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride.
    Takano A; Suhara T; Yasuno F; Suzuki K; Takahashi H; Morimoto T; Lee YJ; Kusuhara H; Sugiyama Y; Okubo Y
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):539-45. PubMed ID: 16288681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
    Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T
    J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
    Schmitt GJ; Meisenzahl EM; Dresel S; Tatsch K; Rossmüller B; Frodl T; Preuss UW; Hahn K; Möller HJ
    J Psychopharmacol; 2002 Sep; 16(3):200-6. PubMed ID: 12236625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological perspectives. Antipsychotics and the "fast-off" theory.
    Steele D; Dowben JS; Vance DE; Keltner NL
    Perspect Psychiatr Care; 2011 Jul; 47(3):160-2. PubMed ID: 21707632
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I; Janouschek H; Raptis M; Hellmann S; Veselinovic T; Bröcheler A; Boy C; Cumming P; Hiemke C; Rösch F; Schäfer WM; Gründer G
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P; Tallerico T
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substituted benzamides].
    Scotto JC
    Encephale; 1975; 1(3):223-5. PubMed ID: 6257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
    Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder.
    Potkin SG; Keator DB; Kesler-West ML; Nguyen DD; van Erp TG; Mukherjee J; Shah N; Preda A
    CNS Spectr; 2014 Apr; 19(2):176-81. PubMed ID: 24073841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG; Gil R; Hackett E; Mawlawi O; Zea-Ponce Y; Zhu Z; Kochan LD; Cangiano C; Slifstein M; Gorman JM; Laruelle M; Abi-Dargham A
    Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse.
    Rominger A; Mille E; Böning G; Wängler B; Josef Gildehaus F; Arszol C; Bartenstein P; Cumming P
    Synapse; 2010 Aug; 64(8):654-7. PubMed ID: 20336625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
    Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Okada H; Minabe Y; Nakamura K; Suzuki K; Iwata Y; Tsuchiya KJ; Sugihara G; Mori N
    J Clin Psychopharmacol; 2006 Oct; 26(5):531-3. PubMed ID: 16974201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.